China Medicine Corp
OTC:CHME
Gross Margin
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Peer Comparison
| Country | Company | Market Cap |
Gross Margin |
||
|---|---|---|---|---|---|
| CN |
|
China Medicine Corp
OTC:CHME
|
974.4k USD |
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
987.9B USD |
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
596.5B USD |
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
293B CHF |
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
249.7B CHF |
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
240.5B GBP |
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
307.4B USD |
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD |
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK |
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
156.9B USD |
Loading...
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
125.6B USD |
Loading...
|
Market Distribution
| Min | -2 148% |
| 30th Percentile | 14.3% |
| Median | 23% |
| 70th Percentile | 34.6% |
| Max | 775.2% |
Other Profitability Ratios
China Medicine Corp
Glance View
China Medicine Corp. engages in the development, manufacture, and sale of western pharmaceuticals, traditional Chinese medicines, and other healthcare products. The company is headquartered in Guangzhou, Guangdong and currently employs 281 full-time employees. The company went IPO on 2005-06-23. The firm is engaged in the production and distribution of prescription and over the counter (OTC) drugs, traditional Chinese medicine products, herbs and dietary-supplements, medical devices, and medical formulations in China. The firm is developing a number of products for a range of indications, including oncology, high blood pressure and the removal of toxins from food and animal feeds. The firm's products include Shuangdan Capsules, Houerhuan Anti-inflammatory Capsules, Shugan Yipi Granules, Danggui Tiaojing Granules, Huangzao Granules, Pingfeng Shengmai Capsules, Danqi Tablets and Naodesheng Tablets. The firm also offers a range of dietary supplements, which include BeThin Tablets, Refrelizer Herbal Tea, LifeFull Herbal Tea and Relaxetox Herbal Tea. Shuangdan Capsules are indicated for the treatment of stagnation of the heart blood, obstruction of qi in the chest and cardiodynia.
See Also
Gross Margin is calculated by dividing the Gross Profit by the Revenue.
Over the last 3 years, China Medicine Corp’s Gross Margin has increased from 32.9% to 33.5%. During this period, it reached a low of 25.6% on Jun 30, 2009 and a high of 33.5% on Sep 30, 2010.
